FCRL3 and systemic lupus erythematosus: Several investigations have implicated FCRL3 and its functional promoter polymorphism -169 T/C in the pathogenesis of various autoimmune disorders, including rheumatoid arthritis, systemic lupus erythematosus, and autoimmune thyroid diseases (18, 21).